JP2009519920A5 - - Google Patents

Download PDF

Info

Publication number
JP2009519920A5
JP2009519920A5 JP2008545048A JP2008545048A JP2009519920A5 JP 2009519920 A5 JP2009519920 A5 JP 2009519920A5 JP 2008545048 A JP2008545048 A JP 2008545048A JP 2008545048 A JP2008545048 A JP 2008545048A JP 2009519920 A5 JP2009519920 A5 JP 2009519920A5
Authority
JP
Japan
Prior art keywords
glass transition
biological product
transition temperature
dry
virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008545048A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009519920A (ja
JP5085558B2 (ja
Filing date
Publication date
Priority claimed from FR0512875A external-priority patent/FR2894830B1/fr
Application filed filed Critical
Publication of JP2009519920A publication Critical patent/JP2009519920A/ja
Publication of JP2009519920A5 publication Critical patent/JP2009519920A5/ja
Application granted granted Critical
Publication of JP5085558B2 publication Critical patent/JP5085558B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008545048A 2005-12-19 2006-12-19 乾燥加熱によるウイルス不活化方法 Expired - Fee Related JP5085558B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0512875 2005-12-19
FR0512875A FR2894830B1 (fr) 2005-12-19 2005-12-19 Procede d'inactivation virale par chauffage a sec selon la temperature de transition vitreuse
PCT/FR2006/002817 WO2007071845A2 (fr) 2005-12-19 2006-12-19 Procede d'inactivation virale par chauffage a sec selon la temperature de transition vitreuse

Publications (3)

Publication Number Publication Date
JP2009519920A JP2009519920A (ja) 2009-05-21
JP2009519920A5 true JP2009519920A5 (https=) 2012-08-16
JP5085558B2 JP5085558B2 (ja) 2012-11-28

Family

ID=36698885

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008545048A Expired - Fee Related JP5085558B2 (ja) 2005-12-19 2006-12-19 乾燥加熱によるウイルス不活化方法

Country Status (16)

Country Link
US (1) US8252227B2 (https=)
EP (1) EP1981549B1 (https=)
JP (1) JP5085558B2 (https=)
KR (1) KR101162060B1 (https=)
CN (1) CN101355972B (https=)
AT (1) ATE431162T1 (https=)
AU (1) AU2006328804B2 (https=)
BR (1) BRPI0621074B1 (https=)
CA (1) CA2633338C (https=)
DE (1) DE602006006875D1 (https=)
DK (1) DK1981549T3 (https=)
ES (1) ES2327279T3 (https=)
FR (1) FR2894830B1 (https=)
IL (1) IL192194A (https=)
PL (1) PL1981549T3 (https=)
WO (1) WO2007071845A2 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20140093603A (ko) 2010-12-30 2014-07-28 라보라토이레 프란카이즈 듀 프락티온네먼트 에트 데스 바이오테크놀로지스 병원체 불활성화제로서의 글리콜
USD689039S1 (en) * 2012-07-12 2013-09-03 Alljack Co., Ltd. Stereo set
CN109444209A (zh) * 2018-10-26 2019-03-08 北京食品科学研究院 一种测量蛋清粉玻璃化转变温度的方法
CN116059410A (zh) * 2021-08-19 2023-05-05 南京金斯瑞生物科技有限公司 一种去除生物样本中噬菌体的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2248817C2 (de) * 1972-10-05 1981-09-24 Bayer Ag, 5090 Leverkusen Polycarbonatmischungen
US4456590B2 (en) * 1981-11-02 1989-05-30 Heat treatment of lyphilized blood clotting factor viii concentrate
GB9424732D0 (en) * 1994-12-08 1995-02-08 Common Services Agency Heat treated blood plasma proteins
US5837519A (en) * 1996-11-21 1998-11-17 Bayer Corporation Dry-heat viral inactivation under controlled moisture conditions
AU9775398A (en) * 1997-09-23 1999-04-12 Ib2, L.L.C. Rapid thermal cycle processing methods and apparatus
CN1286725A (zh) * 1997-11-26 2001-03-07 环球保藏技术股份有限公司 敏感性生物样品的玻化保质法
CA2347242C (en) * 1998-10-14 2008-03-25 Katrina T. Forest Method for vitrification of a biological specimen
CA2396219A1 (en) * 2000-01-04 2001-07-12 Xiangzhong Yang Oocyte vitrification technique
EP1651275A1 (en) * 2003-08-05 2006-05-03 Fuji Photo Film B.V. Use of recombinant or synthetic gelatin-like proteins as stabiliser in lyophilized pharmaceutical compositions

Similar Documents

Publication Publication Date Title
Sabbaghi et al. Inactivation methods for whole influenza vaccine production
Lin et al. High amplification of the antiviral activity of curcumin through transformation into carbon quantum dots
NO20081087L (no) Fremgangsmater for fremstilling av sterilisert pankreatinpulver
JP2014525461A5 (https=)
WO2009091388A3 (en) Triazines and related compounds having antiviral activity, compositions and methods thereof
WO2011082388A3 (en) Infectious dna vaccines against chikungunya virus
BRPI0309631A8 (pt) vacina tetravalente da dengue contendo uma trivial deleção de 30 nucleotídeos na utr-31' dos tipos de dengue 1,2,3 e 4, ou de vírus antigênicos quiméricos da dengue 1,2,3 e 4
CN101636486A (zh) 保存病毒颗粒的方法
WO2008092854A3 (en) Papillomavirus e2 polypeptide used for vaccination
WO2008133663A3 (en) Codon modified immunogenic compositions and methods of use
EA201290152A1 (ru) Антисмысловые ингибиторы вируса гепатита в (hbv)
WO2009029384A3 (en) Compounds for the treatment of hepatitis c
WO2006136448A3 (en) Attenuated sars and use as a vaccine
Chen et al. Molecular evidence and sequence analysis of a natural reassortant between Cucumber mosaic virus subgroup IA and II strains
JP2009519920A5 (https=)
WO2022026885A3 (en) Modified chikungunya viruses and sindbis viruses and uses thereof
WO2010008576A3 (en) Idna vaccines and methods for using the same
JP2016528233A5 (https=)
Caruso et al. Evaluation of viral inactivation of pseudorabies virus, encephalomyocarditis virus, bovine viral diarrhea virus and porcine parvovirus in pancreatin of porcine origin
WO2009152519A3 (en) Novel antiviral peptides against influenza virus
Roberts et al. Effect of manufacturing process parameters on virus inactivation by dry heat treatment at 80 C in factor VIII
CA2633338A1 (en) The invention relates to a method of viral inactivation by dry heating
CN102526751A (zh) 一种猪瘟脾淋源活疫苗耐热冻干保护剂及制备方法
CN110093322A (zh) Mg132作为疫苗生产增效剂及稳定剂的应用
Xiao et al. Inactivation efficacy and mechanism of 9.375 GHz electromagnetic wave on coronavirus